Cancer Care Ontario | Cancer Care Ontario

Systemic Treatment of Acute Myeloid Leukemia (AML)

Systemic therapy for the treatment of adult patients with lower-risk myelodysplastic syndromes

Role of Adjuvant Treatment in Resected Pancreatic Ductal Adenocarcinoma

Stem Cell Transplantation in the Treatment of Acute Lymphoblastic Leukemia: Recommendations

Magnetic Resonance Imaging for Pre-Treatment Local Staging of Prostate Cancer

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

Safe Administration of Systemic Cancer Therapy Part 2: Administration of Systemic Treatment and Management of Preventable Adverse Events

The Use of Systemic Treatment in the Maintenance of Patients with Non-Small Cell Lung Cancer

Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-Based Chemotherapy and Radiation

Endorsement of the 2018 American Society of Clinical Oncology Treatment of Malignant Pleural Mesothelioma Guideline

Recommendations for the Treatment of Patients with Clinical Stage III Non-Small Cell Lung Cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance and the 2018 Society for Immunotherapy of Cancer Guidance

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib (Iressa®), Erlotinib (Tarceva®), Afatinib, Dacomitinib or Icotinib in the Treatment of Non–SmallCell Lung Cancer: A Clinical Practice Guideline